Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)
Ison et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofad314
https://c19early.org/ison.html